18.4% CAGR for Genome Editing Market Worth $16.98 Billion, Globally, by 2028 Lead by CRISPR Segment During 2021-2028 | The Insight Partners
June 23, 2023 14:02 ET
|
The Insight Partners
Pune, India, June 23, 2023 (GLOBE NEWSWIRE) -- According to our latest study on "Genome Editing Market Size Report, Forecast to 2028 – COVID-19 Impact and Global Analysis – by Technology,...
Global Epigenetic Therapeutics Market to Reach $9.8 Billion by 2028 - Projected Revenue Shares for PRAP, Kinase, IDH, HDAC, DNMT, and KMT Inhibitors
June 23, 2023 05:08 ET
|
Research and Markets
Dublin, June 23, 2023 (GLOBE NEWSWIRE) -- The "Epigenetic Therapeutics: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global epigenetic therapeutics market was...
US Cell & Gene Therapy Market Report 2023 to 2028 - Featuring bluebird bio, Gilead Sciences, Spark Therapeutics, Novartis and Bristol-Myers Squibb Among Others
June 23, 2023 04:13 ET
|
Research and Markets
Dublin, June 23, 2023 (GLOBE NEWSWIRE) -- The "US Cell & Gene Therapy Market - Focused Insights 2023-2028" report has been added to ResearchAndMarkets.com's offering. The US cell and gene...
Global Gene Therapy Market Report 2023: Promising Gene Therapy Innovations for Treatment of Inherited Retinal Diseases
June 22, 2023 05:03 ET
|
Research and Markets
Dublin, June 22, 2023 (GLOBE NEWSWIRE) -- The "Gene Therapy: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Gene Therapy...
World Cell and Gene Therapy Deals Analysis Report 2023: Deals Amounted to $40 Billion in 2022 - Companies Receive Large Amounts of Investments Despite a Decline from 2021 Levels of Investment
June 20, 2023 05:33 ET
|
Research and Markets
Dublin, June 20, 2023 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Market and Deals Analysis, 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals" report...
UAE Gene Editing Technology Databook 2023: Compound Annual Growth of 8.4% Forecast During 2023-2027
June 13, 2023 04:03 ET
|
Research and Markets
Dublin, June 13, 2023 (GLOBE NEWSWIRE) -- The "UAE Gene Editing Technology Databook 2023" has been added to ResearchAndMarkets.com's offering.The UAE gene editing technology market is expected to...
Caribou Biosciences to Participate in Upcoming Investor Conferences
May 31, 2023 16:00 ET
|
Caribou Biosciences, Inc.
BERKELEY, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel...
Caribou Biosciences Reports First Quarter 2023 Financial Results and Provides Business Update
May 09, 2023 16:00 ET
|
Caribou Biosciences, Inc.
-- CB-010 ANTLER Phase 1 trial enrolling second-line LBCL patients in dose expansion; plan to report dose escalation data in H2 2023 -- -- CB-011 CaMMouflage Phase 1 trial enrolling r/r MM patients...
Caribou Biosciences Announces Appointment of Stephen J. Schuster, MD, to its Scientific Advisory Board
May 08, 2023 09:00 ET
|
Caribou Biosciences, Inc.
-- Dr. Schuster is a world-renowned hematologist and pioneer in CAR-T cell therapy development -- BERKELEY, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a...
Intellia Therapeutics Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
May 04, 2023 07:30 ET
|
Intellia Therapeutics, Inc.
Dosed first patient in the global Phase 2 study of NTLA-2002 for the treatment of hereditary angioedema (HAE)Expects to complete enrollment in the Phase 2 study of NTLA-2002 in 2H 2023Plans to submit...